Institute Financial Statements From 2010 to 2024
| MRES Stock | USD 0.01 0.0006 8.11% |
Check Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Institute's main balance sheet or income statement drivers, such as , as well as many indicators such as . Institute financial statements analysis is a perfect complement when working with Institute Valuation or Volatility modules.
Institute |
Institute of Biomedical Company Shares Outstanding Analysis
Institute's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Institute Shares Outstanding | 66.28 M |
Most of Institute's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Institute of Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Institute of Biomedical has 66.28 M of shares currently outstending. This is 63.29% lower than that of the Healthcare sector and 37.97% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 88.41% higher than that of the company.
Institute of Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Institute's current stock value. Our valuation model uses many indicators to compare Institute value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Institute competition to find correlations between indicators driving Institute's intrinsic value. More Info.Institute of Biomedical is rated below average in current valuation category among its peers. It is regarded second in shares outstanding category among its peers creating about 333.33 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Institute's earnings, one of the primary drivers of an investment's value.About Institute Financial Statements
Institute shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Institute investors may analyze each financial statement separately, they are all interrelated. The changes in Institute's assets and liabilities, for example, are also reflected in the revenues and expenses on on Institute's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada. Institute is traded on OTC Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Institute Pink Sheet Analysis
When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.